Our results show that internationally recommended MDR-TB treatment regimens were infrequently used and that ART use and viral suppression was well below the target of 90%, reflecting the challenging patient population and the environment in which health care is provided. Urgent improvement of management of patients with TB/HIV in EE, in particular for those with MDR-TB, is needed and includes widespread access to rapid TB diagnostics, better access to and use of second-line TB drugs, timely ART initiation with viral load monitoring, and integration of TB/HIV care.
The medical and social status, clinical structure are analyzed and the most significant risk factors of mortality among 83 patients who died from HIV-associated tuberculosis are determined. It is found that they are men 30-40 with sharp generalized forms of tuberculosis, resulting in death in the first two years. The most important predictors of mortality of patients stage of HIV-infection, HIV-associated cachexia, a form of pulmonary tuberculosis, the count of leukocytes and CD4 + T-lymphocytes are were.
The review dedicated to a problem of a tuberculosis at the HIV-infected persons. The modern data on epidemiology, pathogenesis, clinic and diagnostics of the HIV-associated tuberculosis are resulted. The article described treatment HIV/ТB-infection, chemoprophylaxis the latent tuberculosis.
The social and medical status of patients with HIV-associated tuberculosis are investigated, groups of risk of development of a double infection are allocated. They are single men 30-40, with the secondary education, living of a city, the drug addicts abusing alcohol, who were in prison, with a chronic hepatitis C virus infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.